Page 416 - Read Online

Page 6 of 6 Paraskevas et al. Neuroimmunol Neuroinflammation 2018;5:49 I http://dx.doi.org/10.20517/2347-8659.2018.50

cal Infarcts and Leukoencephalopathy (CADASIL) Scale: a screening tool to select patients for NOTCH3 gene analysis. Stroke
2012;43:2871-6.
9. He D, Chen D, Li X, Hu Z, Yu Z, et al. The comparisons of phenotype and genotype between CADASIL and CADASIL-like patients
and population-specific evaluation of CADASIL scale in China. J Headache Pain 2016;17:55.
10. Pandey T, Abubacker S. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: an imaging
mimic of multiple sclerosis. A report of two cases. Med Princ Pract 2006;15:391-5.
11. Paraskevas GP, Bougea A, Synetou M, Vassilopoulou S, Anagnostou E, et al. CADASIL and autoimmunity: coexistence in a family
with the R169C mutation at exon 4 of the NOTCH3 gene. Cerebrovasc Dis 2014;38:302-7.
12. Paraskevas GP, Constantinides VC, Bougea A, Gerakoulis E, Yapijakis C, et al. Cerebral autosomal dominant arteriopathy with subcor-
tical infarcts and leukoencephalopathy presenting with postpartum psychosis and late-onset stroke. Future Neurol 2016;1:207-13.
13. Joshi S, Yau W, Kermode A. CADASIL mimicking multiple sclerosis: The importance of clinical and MRI red flags. J Clin Neurosci
2017;35:75-7.
14. Carone DA. CADASIL and multiple sclerosis: A case report of prolonged misdiagnosis. Appl Neuropsychol Adult 2017;24:294-7.
15. Broadley SA, Sawcer SJ, Chataway SJ, Coraddu F, Coles A, et al. No association between multiple sclerosis and the Notch3 gene re-
sponsible for cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). J Neurol Neu-
rosurg Psychiatry 2001;71:97-9.
16. Del Río Espínola A, Solé E, Montaner J. Pathophysiology of CADASIL disease. Med Clin (Barc) 2010;135:222-30.
17. Pantoni L, Sarti C, Pescini F, Bianchi S, Bartilini L, et al. Thrombophilic risk factors and unusual clinical features in three Italian CA-
DASIL patients. Eur J Neurol 2004;11:782-7.
18. Schmidley JW, Beadle BA, Trigg L. Co-occurrence of CADASIL and isolated CNS angiitis. Cerebrovasc Dis 2005;19:352-4.
19. Nannucci S, Pescini F, Valenti R, Ciolli L, Bianchi S, et al. Stroke recurrence in an elderly CADASIL patient on aspirin discontinuation
due to severe auto-immune thrombocytopenia. Aging Clin Exp Res 2010;22:98-9.
20. Kusaba T, Hatta T, Kimura T, Sonomura K, Tanda S, et al. Renal involvement in cerebral autosomal dominant arteriopathy with subcor-
tical infarcts and leucoencephalopathy (CADASIL). Clin Nephrol 2007;67:182-7.
21. Ragno M, Trojano L, Pianese L, Boni MV, Silvestri S, et al. Renal involvement in cerebral autosomal dominant arteriopathy with sub-
cortical infarcts and leukoencephalopathy (CADASIL): report of a case with a six-year follow-up. Histol Histopathol 2012;27:1307-14.
22. Chabriat H, Vahedi K, Bousser MG, Iba-Zizen MT, Joutel A, et al. Clinical spectrum of CADASIL: a study of 7 families. Cerebral auto-
somal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Lancet 1995;346:934-9.
23. Dichgans M, Wick M, Gasser T. Cerebrospinal fluid findings in CADASIL. Neurology 1999;53:233.
24. Hinze S, Goonasekera M, Nannucci S, Quaghebeur G, Briley D, et al. Longitudinally extensive spinal cord infarction in CADASIL.
Pract Neurol 2015;15:60-2.
25. Pinto WB, Souza PV, Oliveira AS. Longitudinally extensive transverse myelopathy in a patient with CADASIL. Arq Neuropsiquiatr
2015;73:812.
26. Bentley P, Wang T, Malik O, Nicholas R, Ban M, et al. CADASIL with cord involvement associated with a novel and atypical NOTCH3
mutation. J Neurol Neurosurg Psychiatry 2011;82:855-60.
27. Collongues N, Derache N, Blanc F, Labauge P, de Seze J, et al. Inflammatory-like presentation of CADASIL: a diagnostic challenge.
BMC Neurol 2012;12:78.
28. Schiess N, Huether K, Szolics M, Agarwal G, El-Hattab AW, et al. Multiple sclerosis or “inflammatory CADASIL?”: Case Report and
review of the literature. Clin Neurol Neurosurg 2018; doi: 10.1016/j.clineuro.2018.01.035
29. Chitnis T, Hollmann TJ. CADASIL mutation and Balo concentric sclerosis: a link between demyelination and ischemia? Neurology
2012;78:221-3.
30. Rampal R, Luther KB, Haltiwanger RS. Notch signaling in normal and disease States: possible therapies related to glycosylation. Curr
Mol Med 2007;7:427-45.
31. Jurynczyk M, Jurewicz A, Raine CS, Selmaj K. Notch3 inhibition in myelin-reactive T cells down-regulates protein kinase C theta and
attenuates experimental autoimmune encephalomyelitis. J Immunol 2008;180:2634-40.
32. Monet-Leprêtre M, Haddad I, Baron-Menguy C, Fouillot-Panchal M, Riani M, et al. Abnormal recruitment of extracellular matrix pro-
teins by excess Notch3ECD: a new pathomechanism in CADASIL. Brain 2013;136:1830-45.
33. Kavanagh D, Spitzer D, Kothari PH, Shaikh A, Liszewski MK, et al. New roles for the major human 3’-5’ exonuclease TREX1 in hu-
man disease. Cell Cycle 2008;7:1718-25.
34. Finsterer J, Zarrouk-Mahjoub S. Autoimmunity in MELAS. Ann Clin Lab Sci 2018;48:255-6.
35. Harris MO, Walsh LE, Hattab EM, Golomb MR. Is it ADEM, POLG, or both? Arch Neurol 2010;67:493-6.
36. Yu-Wai-Man P, Griffiths PG, Gorman GS, Lourenco CM, Wright AF, et al. Multi-system neurological disease is common in patients
with OPA1 mutations. Brain 2010;133:771-86.
37. Koutroulou I, Karapanayiotides T, Grigoriadis N, Karacostas D. CADASIL presenting with spontaneous intracerebral hemorrhage: re-
port of a case and description of the first family in Northern Greece. Hippokratia 2016;20:76-9.